The evaluation of drugs for listing purposes was updated in July 2018 following recent developments in the area of drug evaluation and new, innovative therapies.
This document explains the drug evaluation approach used at INESSS. It includes a description of the basic principles that apply to all products that we assess for listing purposes.
